BioCardia raises $4.4M in financing to extend cash runway into Q1 2027
BioCardia sold 3.5M shares at $1.279 per share on June 5, 2026, raising $4.4M in net proceeds. The capital is intended to fund operations through Q1 2027 and support the company's Japan PMDA submission for its CardiAMP cell therapy platform.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day